HRP20080100T3 - Hydroisoindoline tachykinin receptor antagonists - Google Patents
Hydroisoindoline tachykinin receptor antagonistsInfo
- Publication number
- HRP20080100T3 HRP20080100T3 HR20080100T HRP20080100T HRP20080100T3 HR P20080100 T3 HRP20080100 T3 HR P20080100T3 HR 20080100 T HR20080100 T HR 20080100T HR P20080100 T HRP20080100 T HR P20080100T HR P20080100 T3 HRP20080100 T3 HR P20080100T3
- Authority
- HR
- Croatia
- Prior art keywords
- 6alkyl
- receptor antagonists
- tachykinin receptor
- hydroisoindoline
- unsubstituted
- Prior art date
Links
- 239000002462 tachykinin receptor antagonist Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53991304P | 2004-01-27 | 2004-01-27 | |
US56122704P | 2004-04-09 | 2004-04-09 | |
PCT/US2005/002149 WO2005073191A1 (fr) | 2004-01-27 | 2005-01-26 | Antagonistes des recepteurs de l'hydroisoindoline tachykinine |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20080100T3 true HRP20080100T3 (en) | 2008-04-30 |
Family
ID=34830494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20080100T HRP20080100T3 (en) | 2004-01-27 | 2008-03-06 | Hydroisoindoline tachykinin receptor antagonists |
Country Status (31)
Country | Link |
---|---|
US (3) | US7645790B2 (fr) |
EP (1) | EP1711465B1 (fr) |
JP (1) | JP3987100B2 (fr) |
KR (1) | KR20060127927A (fr) |
AR (1) | AR047439A1 (fr) |
AT (1) | ATE382034T1 (fr) |
AU (1) | AU2005207934B2 (fr) |
BR (1) | BRPI0507050A (fr) |
CA (1) | CA2554550C (fr) |
CO (1) | CO5700771A2 (fr) |
CR (1) | CR8522A (fr) |
CY (1) | CY1107167T1 (fr) |
DE (1) | DE602005004011T2 (fr) |
DK (1) | DK1711465T3 (fr) |
EA (1) | EA010598B1 (fr) |
EC (1) | ECSP066716A (fr) |
ES (1) | ES2297687T3 (fr) |
GE (1) | GEP20094691B (fr) |
HK (1) | HK1100937A1 (fr) |
HR (1) | HRP20080100T3 (fr) |
IL (1) | IL176879A0 (fr) |
MA (1) | MA28359A1 (fr) |
NI (1) | NI200600164A (fr) |
NO (1) | NO339041B1 (fr) |
NZ (1) | NZ548415A (fr) |
PE (1) | PE20050687A1 (fr) |
PL (1) | PL1711465T3 (fr) |
PT (1) | PT1711465E (fr) |
TW (1) | TWI341198B (fr) |
UA (1) | UA84192C2 (fr) |
WO (1) | WO2005073191A1 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI341198B (en) * | 2004-01-27 | 2011-05-01 | Merck Sharp & Dohme | Hydroisoindoline tachykinin receptor antagonists |
CA2590039A1 (fr) * | 2004-12-14 | 2006-06-22 | Merck & Co., Inc. | Antagonistes du recepteur de tachykinine d'octahydropyrano[3,4-c]pyrrole |
EP1898905A4 (fr) * | 2005-06-27 | 2010-06-23 | Merck Sharp & Dohme | Antagonistes des recepteurs de tachykinine hydro-iso-indolique |
AU2006269383A1 (en) | 2005-07-11 | 2007-01-18 | Merck Sharp & Dohme Corp. | Process for making hydroisoindoline tachykinin receptor antagonists |
AU2006302562A1 (en) * | 2005-10-04 | 2007-04-19 | Merck Sharp & Dohme Corp. | Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
US20090048248A1 (en) * | 2005-12-22 | 2009-02-19 | Devita Robert J | Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor Antagonists |
US20090042854A1 (en) * | 2006-01-24 | 2009-02-12 | Jianming Bao | Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists |
US20100209496A1 (en) * | 2006-09-06 | 2010-08-19 | Eleni Dokou | Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
US20090270477A1 (en) * | 2006-11-02 | 2009-10-29 | Kuethe Jeffrey T | Polymorphs of a hydroisoindoline tachykinin receptor antagonist |
JP2010522751A (ja) * | 2007-03-29 | 2010-07-08 | メルク・シャープ・エンド・ドーム・コーポレイション | 下部尿路症状の治療のための併用療法 |
WO2008124143A1 (fr) | 2007-04-10 | 2008-10-16 | Merck & Co., Inc. | Antagonistes hydroisoindolines d'éther hydroxyméthyle des récepteurs de tachykinine |
CA2796877A1 (fr) | 2010-04-30 | 2011-11-03 | Merck Sharp & Dohme Corp. | Nouveaux agonistes du recepteur beta 3 adrenergique |
US8627816B2 (en) | 2011-02-28 | 2014-01-14 | Intelliject, Inc. | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
EP2729147B1 (fr) | 2011-07-04 | 2017-09-06 | IRBM - Science Park S.p.A. | Antagonistes des récepteurs nk-1 pour traiter une néovascularisation cornéenne |
US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
AU2014302694B2 (en) | 2013-06-24 | 2019-10-17 | Menlo Therapeutics Inc. | Use of NK-1 receptor antagonist serlopitant in pruritus |
US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
EA201992414A1 (ru) | 2017-04-10 | 2020-03-16 | Чейс Терапьютикс Корпорейшн | Комбинация nk1-антагониста и способ лечения синуклеинопатий |
JP7158425B2 (ja) | 2017-06-30 | 2022-10-21 | チェイス セラピューティクス コーポレイション | Nk-1アンタゴニスト組成物およびうつ病の処置における使用法 |
CA3091944A1 (fr) | 2018-02-26 | 2019-08-29 | Ospedale San Raffaele S.R.L. | Antagonistes nk-1 destines a etre utilises dans le traitement de la douleur oculaire |
WO2021180885A1 (fr) | 2020-03-11 | 2021-09-16 | Ospedale San Raffaele S.R.L. | Traitement d'une déficience en cellules souches |
BR112022018876A2 (pt) | 2020-04-03 | 2022-11-22 | Nerre Therapeutics Ltd | Antagonista de receptor de nk-1 para tratar uma doença selecionada a partir de sepse, choque séptico, síndrome de desconforto respiratório agudo (ards) ou síndrome de disfunção múltipla dos órgãos |
AU2021285503A1 (en) | 2020-06-02 | 2022-12-08 | Nerre Therapeutics Limited | Neurokinin (NK)-1 receptor antagonists for use in the treatment of pulmonary fibrosis conditions promoted by mechanical injury to the lungs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5650142A (en) * | 1995-09-27 | 1997-07-22 | Church & Dwight Co., Inc. | Bicarbonate-containing deodorant cosmetic stick compositions |
WO1997014671A1 (fr) * | 1995-10-18 | 1997-04-24 | Merck & Co., Inc. | Antagonistes des recepteurs de la cyclopentyle-tachykinine |
WO2005032464A2 (fr) | 2003-09-30 | 2005-04-14 | Merck & Co., Inc. | Antagonistes du recepteur de la tachykinine a base de phenyle pyrrolidine ether |
TWI341198B (en) | 2004-01-27 | 2011-05-01 | Merck Sharp & Dohme | Hydroisoindoline tachykinin receptor antagonists |
-
2005
- 2005-01-20 TW TW094101721A patent/TWI341198B/zh not_active IP Right Cessation
- 2005-01-20 AR ARP050100203A patent/AR047439A1/es active IP Right Grant
- 2005-01-24 PE PE2005000090A patent/PE20050687A1/es not_active Application Discontinuation
- 2005-01-26 US US10/586,727 patent/US7645790B2/en active Active
- 2005-01-26 CA CA2554550A patent/CA2554550C/fr not_active Expired - Fee Related
- 2005-01-26 BR BRPI0507050-3A patent/BRPI0507050A/pt not_active IP Right Cessation
- 2005-01-26 KR KR1020067015184A patent/KR20060127927A/ko not_active Application Discontinuation
- 2005-01-26 NZ NZ548415A patent/NZ548415A/en not_active IP Right Cessation
- 2005-01-26 ES ES05726323T patent/ES2297687T3/es active Active
- 2005-01-26 PL PL05726323T patent/PL1711465T3/pl unknown
- 2005-01-26 AT AT05726323T patent/ATE382034T1/de active
- 2005-01-26 WO PCT/US2005/002149 patent/WO2005073191A1/fr active IP Right Grant
- 2005-01-26 UA UAA200609315A patent/UA84192C2/ru unknown
- 2005-01-26 AU AU2005207934A patent/AU2005207934B2/en not_active Ceased
- 2005-01-26 EA EA200601378A patent/EA010598B1/ru not_active IP Right Cessation
- 2005-01-26 DE DE602005004011T patent/DE602005004011T2/de active Active
- 2005-01-26 EP EP05726323A patent/EP1711465B1/fr active Active
- 2005-01-26 GE GEAP20059594A patent/GEP20094691B/en unknown
- 2005-01-26 DK DK05726323T patent/DK1711465T3/da active
- 2005-01-26 PT PT05726323T patent/PT1711465E/pt unknown
- 2005-01-26 JP JP2006551356A patent/JP3987100B2/ja not_active Expired - Fee Related
- 2005-01-26 US US11/043,213 patent/US7217731B2/en active Active
-
2006
- 2006-07-16 IL IL176879A patent/IL176879A0/en unknown
- 2006-07-19 CR CR8522A patent/CR8522A/es not_active Application Discontinuation
- 2006-07-21 EC EC2006006716A patent/ECSP066716A/es unknown
- 2006-07-26 NI NI200600164A patent/NI200600164A/es unknown
- 2006-07-27 CO CO06073837A patent/CO5700771A2/es active IP Right Grant
- 2006-08-11 MA MA29265A patent/MA28359A1/fr unknown
- 2006-08-25 NO NO20063810A patent/NO339041B1/no not_active IP Right Cessation
-
2007
- 2007-03-06 US US11/714,352 patent/US7345083B2/en active Active
- 2007-08-09 HK HK07108650.7A patent/HK1100937A1/xx not_active IP Right Cessation
-
2008
- 2008-01-31 CY CY20081100113T patent/CY1107167T1/el unknown
- 2008-03-06 HR HR20080100T patent/HRP20080100T3/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20080100T3 (en) | Hydroisoindoline tachykinin receptor antagonists | |
RS51136B (sr) | Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba | |
HRP20080666T3 (en) | Cgrp receptor antagonists | |
TW200724136A (en) | Pharmaceutical compositions comprising PPAR modulator | |
HRP20070510T3 (en) | Benzimidazole derivative and its use as a ii receptor antagonist | |
HRP20100614T1 (en) | 3,7-diamino-10h-phenothiazine salts and their use | |
NO20055568L (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
RS51200B (sr) | (imidazol-1-il-metil)-piridazin kao blokator nmda receptora | |
SE0302760D0 (sv) | New compounds | |
RS52953B (en) | PYRIDOPINIDINONSKI INHIBITORI PI3 KALFA | |
RS53029B (en) | CARBONYLAMINE PIROLOPYRAZOLES, POWERFUL KINASE INHIBITORS | |
RS52978B (en) | FUSIONED AMINO PIRIDIN AS HSP90 INHIBITORS | |
AR033046A1 (es) | Derivados de 4,5-dihidro-1h-pirazol que tienen actividad antagonista de cb1, composicion farmaceutica y metodos de preparacion | |
RS53279B (en) | MONODISPERSE MIXTURES OF PEGYLATED NALOXOL | |
ATE406360T1 (de) | Antagonisten der opioidrezeptoren | |
MXPA05009969A (es) | Metodo para aislar la forma cristalina i de la 5-azacitidina. | |
RS53059B (en) | NEW SUBSTITUTED IMIDAZOCHINOLINES | |
RS52865B (en) | Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
RS51674B (en) | PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS | |
TW200611687A (en) | Pharmaceutical compositions used for immunosuppressant | |
NO20063230L (no) | CRF receptorantagonister og fremgangsmater for fremstilling derav | |
CA2511255A1 (fr) | Derives de 2-piperidone agonistes de la prostaglandine | |
DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
DE60302157D1 (de) | Opioidrezeptorantagonisten |